Broad Institute Executive and Leadership Team

Emme Handy, the Chief Financial Officer at Broad Institute, directs all fiscal planning and resource allocation to support large-scale genomic research initiatives. Overseeing the financial health of the organization, the Chief Financial Officer ensures that capital investments align with long-term scientific goals. This leadership role involves managing complex budgetary frameworks across diverse research programs while maintaining rigorous compliance standards. By optimizing funding structures and grant management, Emme Handy directly impacts the ability of the institute to pursue high-risk, high-reward biological studies. Ultimately, Handy secures the economic stability necessary for sustained innovation in human disease treatment, providing the essential financial foundation for the entire research enterprise to thrive within the competitive global scientific landscape.

Dan Shore, the Chief Operating Officer at Broad Institute, manages the daily operational infrastructure required to sustain world-class biomedical research. Overseeing facility logistics and administrative workflows, the Chief Operating Officer ensures that laboratory environments remain optimized for high-throughput genomic sequencing and data analysis. This leadership role involves coordinating cross-departmental resources to streamline the transition from basic biological discovery to clinical application. By refining internal processes and operational efficiency, Dan Shore directly impacts the speed at which new therapies reach the development pipeline. Ultimately, Shore maintains the structural integrity of the organization, allowing scientific teams to focus exclusively on solving complex medical challenges through advanced technology and collaborative research efforts across the entire research campus.

Jennifer Hopkins, the Chief Information Officer at Broad Institute, architects the digital infrastructure and data management systems essential for modern genomic research. Overseeing the computational platforms that process massive biological datasets, the Chief Information Officer ensures that researchers possess the tools required for rapid discovery. This leadership role involves securing sensitive information while fostering an environment of open data sharing to accelerate scientific breakthroughs. By implementing scalable cloud solutions and advanced analytics, Jennifer Hopkins directly impacts the efficiency of the institute's computational biology programs. Ultimately, Hopkins drives the digital transformation of the organization, ensuring that information technology remains a primary catalyst for innovation in the ongoing search for new treatments for human diseases.

Emily Botelho, the Chief of Staff & To David R Liu Senior Advisor at Broad Institute, coordinates strategic initiatives and facilitates communication between executive leadership and research teams. Overseeing the execution of high-priority projects, the Chief of Staff & To David R Liu Senior Advisor ensures that organizational objectives remain synchronized with the broader mission of genomic discovery. This leadership role involves managing complex stakeholder relationships and providing critical guidance on institutional policy. By streamlining decision-making processes, Emily Botelho directly impacts the agility of the research programs led by senior faculty. Ultimately, Botelho maintains the focus of the leadership team, ensuring that strategic resources are effectively deployed to address the most pressing challenges in human health and biological science.

Sarah Cox, the Chief People Officer at Broad Institute, directs talent acquisition, professional development, and organizational culture initiatives. Overseeing the recruitment of world-class scientists and administrative staff, the Chief People Officer ensures that the workforce remains highly skilled and motivated to tackle complex biological problems. This leadership role involves fostering an inclusive environment that encourages collaborative innovation across diverse research disciplines. By implementing comprehensive human capital strategies, Sarah Cox directly impacts the retention of top-tier talent necessary for sustained scientific excellence. Ultimately, Cox builds the organizational framework that supports the people behind the research, ensuring that the institute attracts and retains the brightest minds dedicated to finding new therapies for human diseases.

Lee McGuire, the Chief Communications Officer (Cco) at Broad Institute, manages the public narrative and institutional messaging regarding scientific breakthroughs and research impact. Overseeing internal and external communications, the Chief Communications Officer (Cco) ensures that the mission of the organization is clearly articulated to stakeholders, donors, and the broader scientific community. This leadership role involves translating complex genomic research into accessible information that highlights the value of new therapies. By building strong relationships with media and academic partners, Lee McGuire directly impacts the public perception and reputation of the institute. Ultimately, McGuire drives the communication strategy that supports fundraising and collaborative efforts, ensuring that the world understands the critical importance of the research conducted at the institute.

Ellen Law, the Senior Advisor To the Director at Broad Institute, provides strategic counsel on institutional direction and long-term research planning. Overseeing the alignment of scientific goals with external partnerships, the Senior Advisor To the Director ensures that the institute maintains a leading position in the global biomedical community. This leadership role involves evaluating emerging trends in genomics and advising on the deployment of resources toward high-impact research areas. By facilitating high-level discussions with academic and industry collaborators, Ellen Law directly impacts the strategic trajectory of the organization. Ultimately, Law supports the Director in navigating the complexities of modern science, ensuring that the institute remains at the forefront of discovering new treatments for human diseases.